Clinical trial
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have…
NCT00003077 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003077 |
|---|---|
| Title | Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss |
| Official title | Phase I/II Trial of Omega-3 Fatty Acids for Cancer Cachexia |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Dietary Supplement |
| Interventions | omega-3 fatty acid |
| Enrollment | 63 |
| Start date | Oct 1, 1995 |
| Primary completion | Jul 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | Oct 22, 2003 |
| Last update posted | Jul 13, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: